Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Oxford Immunology Group Logo

The Oxford Immunology Group (OIG) is a regional branch of the British Society for Immunology (BSI). The aim is to connect students, postdocs, early-career researchers, and faculty with an interest in immunology. Within this group, we host the Science in Progress (SIP) talks once every two months and allow for the exchange of reagents, ideas and techniques across institutes and departments in Oxford.

The Science in Progress (SIP) talks are informal research presentations by graduate students, postdocs, or early career researchers to the Oxford immunology community. The SIP talks will take place once every two months and all are welcome to attend.

*** Graduate students, postdocs, and faculty who wish to give presentations please contact Adriana Tomic ***

SIP talks 2022

When: June 29th, 2022, 9:30am

Where: Centre for Cellular and Molecular Physiology (CCMP), The Henry Wellcome Building for Molecular Physiology

Registration link:

    Fran Donnellan (Department of Biochemistry): “Generation and characterisation of synergistic broadly neutralising Ebolavirus Glycoprotein monoclonal antibodies”

    Isabela Pedroza-Pacheco (Nuffield Department of Medicine): “Understanding the immunological environment associated with development of bnAbs in HIV-1 infection to inform vaccine design”



    April 27th, 2022

    Megan Teh (MRC Human Immunology Unit): “Characterisation of T-cell biochemistry during cellular iron restriction”

    Andrew Kwok (Wellcome Centre for Human Genetics): “A neutrophil atlas in sepsis”


    February 23rd, 2022

    Dr. Stephanie Longet (Wellcome Centre for Human Genetics): 'Impact of short or long dosing intervals on humoral and cellular responses to Pfizer/BNT vaccine'

    Dr. Daniel O'Connor (Oxford Vaccine Group): 'Utilising the “-omics” toolkit to elucidate the mechanisms underlying immune responses to immunisation and infection'



    Previous talks


    September 3rd, 2020 talks:

    Dr. Nick Provine: 'MAIT cell activation augments adenovirus vector vaccine immunogenicity’

    Dr. Emma Mead: 'Targeting Neuroinflammation in Alzheimer’s Disease’


    November 5th, 2020 talks:

    Dr. Margarida Rei: 'Enhancing tumour-specific T cell specific responses against glioblastoma'

    Dr. Dominik Aschenbrenner: 'Deconvolution of monocyte responses in inflammatory bowel disease reveals an IL-1 cytokine network that regulates IL-23 in genetic and acquired IL-10 resistance'


    January 21st, 2021 talks:

    Ms Lu Li Jovanoska (Dunn School): Innate and adaptive immune modulation by oxidative stress post-translational modifications

    Dr. Melanie Dunstan (WTCHG/TGU): Single Cell Profiling of Blood and Gut Cells in Patients with Coeliac Disease and Coeliac Disease + Type 1 Diabetes

    Adriana Tomic


    Adriana is leading a Systems Immunology group at the University of Oxford focusing on human immunological memory and recall responses using systems-level analysis, multi-omics data integration and machine learning. She is also a co-developer of SIMON, an open-source platform for the application of machine learning to biological and clinical data.

    Caitlin O’Brien-Ball

    Caitlin O’Brien-Ball, Co-CHAIR

    After graduating with a degree in Biomedical Sciences from Queen Mary, University of London, Caitlin moved to Oxford to start her 4 year DPhil at the Radcliffe Department of Medicine, supervised by Prof. Simon Davis and Dr. Mafalda Santos. 

    Caitlin's studies in the Davis Lab are focussed on the regulation and mechanisms of T cell receptor triggering, including the role of cell topology and signalling microclustersAdditionally, in collaboration with the Klenerman group at the University of Cambridge, she is involved in work using super-resolution microscopy to investigate how our current understanding of T cell receptor triggering may apply to other lymphocyte receptors.  

    Throughout her time in Oxford she has had an active role in many committees, as she enjoys giving back to her local community of students and scientists. 

    May Sin Ke

    May Sin Ke, Secretary 

    May graduated from University of Tsukuba, Japan in 2019 with a BSc in Bio-Resource where she worked under the supervision of Prof. Hiroko Isoda on developing 3D spheriod culture model of primary dermal papilla cell lines to study the effects of natural compounds on hair growth. Currently, she is a DPhil Oncology candidate from the University of Oxford, UK. Tumor heterogeneity is an important factor contributing to cancer immunotherapy resistance. She is interested in studying how tumors can be primed for a better response to the immune checkpoint inhibitors through a combination of biological and computational modelling methods. Her research focuses on investigating the tumour heterogeneity in triple negative breast cancer under acute and chronic hypoxia using methods such as single-cell RNA sequencing and 3D biological models.

    Quang Nguyen

    Quang Nguyen, Public Engagement Lead

    Quang obtained a BS in cell and molecular biology from Duke University, US and an Erasmus LIVE MSc in vaccinology where he interned at GSK Vaccines, BE. Currently, he is an Oxford-Hoffmann DPhil candidate at the University of Oxford, UK. His research integrates high-parameter experimental and computational analyses to identify novel CD8 T cells with immune regulatory functions in human lymphoid tissues. Previously, Quang explored HIV/SIV B cell immunology in the lab of Dr. Sallie Permar at the Duke Human Vaccine Institute, and HIV T cell immunology in the lab of Dr. Richard Koup and Dr. Joseph Casazza at the US NIH Vaccine Research Center.

    Joining OIG, Quang aims to bring the exciting advances in immunology research within and outside of Oxford to a wider community. 

    Carolyn Nielsen

    Carolyn Nielsen, Science in Progress co-Lead

    Carolyn is a Sir Henry Wellcome Postdoctoral Fellow working with Prof Simon Draper’s Blood-Stage Malaria Group in the Department of Biochemistry. Her research centres on interrogating the impact of vaccine platform and dosing regimen on the cellular drivers of humoral immunity using a combination of flow cytometry, systems serology, and single cell RNA sequencing. Carolyn also runs the upstream single B cell sorting for a variety of mAb production projects and is involved in the Draper group’s controlled human malaria infection (CHMI) model and transfer of this model to colleagues at the Ifakara Health Insititute (Tanzania).

    Prior to moving to Oxford, Carolyn completed her PhD at the London School of Hygiene and Tropical Medicine under the supervision of Prof Eleanor Riley. Her PhD work, supported by an MRC Vaccine Research studentship, focused on the impact of human cytomegalovirus infection on natural killer cell responses to vaccines.

    During both her PhD and a prior internship at the World Health Organization, Carolyn has been involved with leading “work-in-progress" programmes similar to the OIG SIP series and is keen to support students and early career researchers develop thnetworking and presentations skills.

    Lisa Stockdale


    Lisa is a post-doctoral immunologist in the team of Katie Ewer at the Jenner Institute. Currently focused on Phase III clinical trial set up for a virus-like particle pre-erythrocytic vaccine candidate, Lisa is establishing antibody-dependent functional assays to investigate a correlate of vaccine-induced protection.

    Prior to joining the Jenner Institute, Lisa was a post-doctoral researcher at the Oxford Vaccine Group where she first worked on vaccines against Salmonella Typhi, and latterly on SARS CoV2 vaccine clinical trials. Lisa completed her PhD at the London School of Hygiene and Tropical Medicine under the supervision of Prof Helen Fletcher. Her PhD work, supported by an MRC Vaccine Research studentship, focused on the interaction between human cytomegalovirus and tuberculosis.

    During her PhD, Lisa was a departmental and TB vaccine Centre student representative where she organised science in progress events for students and early career researchers. 

    Ricardo Fernandes


    Ricardo Fernandes recently joined CAMS Oxford Institute coming from Stanford where he developed novel molecules to effectively shut down signaling by immune receptors such as PD-1.

    Please get in touch with us if you would be interested in joining the OIG committee!

    We are always looking for new members to join - please spread the word!

    Become a Member today

    Stay up to date by checking upcoming Science in Progress talks, following us on Twitter, and subscribing to our mailing list!

    The OIG members share their reagents and equipment, ideas, protocols, and support, subscribe to participate!

    To subscribe to our mailing list, please send an email to with the following title:

    subscribe oig-general (or oig-exchange) Firstname Lastname

    For further instruction please check this link:

    For more information please contact Adriana Tomic.